Noradrenaline versus dopamine in the treatment of circulatory shock

Abstract

There is no difference in the rate of death between individuals randomised to receive dopamine or noradrenaline as first-line treatment of circulatory shock. However, the use of dopamine was associated with a greater incidence of adverse events, especially in those patients with cardiogenic shock. © The Intensive Care Society 2010.